\-\ Texto\\:\\ \ \(0\)\
\-\ an\\ alert\\,\\ interactive\\ adolescent\\.\\ he\\ is\\ afebrile\\.\\ his\\ pulse\\ is\\ 88\\,\\ respiratory\\ rate\\ is\\ 18\\.\\ \\ the\\ head\\ is\\ normocephalic\\.\\ he\\ has\\ marked\\ edema\\ of\\ his\\ left\\ eyelid\\ with\\ significant\\ proptosis\\ as\\ well\\ as\\ downward\\ displacement\\ of\\ the\\ left\\ eye\\ orbit\\.\\ he\\ has\\ soft\\ tissue\\ edema\\ extending\\ onto\\ his\\ forehead\\ without\\ warmth\\ or\\ erythema\\.\\ he\\ has\\ continuous\\ active\\ drainage\\ from\\ his\\ left\\ naris\\.\\ his\\ right\\ septum\\ is\\ erythematous\\ but\\ otherwise\\ normal\\.\\ mucous\\ membranes\\ are\\ moist\\.\\ \\ tongue\\ has\\ some\\ bluish\\ patchy\\ discoloration\\ which\\ is\\ localized\\ along\\ the\\ lateral\\ edges\\ of\\ his\\ tongue\\ bilaterally\\,\\ more\\ prominent\\ on\\ the\\ left\\.\\ \ \(0\)\
\-\ white\\ blood\\ cell\\ count\\ of\\ 13\\,700\\ without\\ a\\ shift\\ to\ \(0\)\
\-\ the\\ left\\.\\ hemoglobin\\ is\\ 13\\.7\\ gm\\/dl\\,\\ platelet\\ count\\ is\\ 132\\,000\\.\\ blood\\ culture\\ no\\ growth\\ after\\ 5\\ days\\.\ \(0\)\
\-\ ent\\ and\\ id\\ were\\ consulted\\.\\ \\ the\\ patient\\ was\\ started\\ on\\ meropenem\\ and\\ vancomycin\\.\\ maximize\\ trough\\ vancomycin\\ level\\ to\\ at\\ least\\ 15\\-20\\ mcg\\/ml\\.\\ \\ the\\ patient\\ had\\ surgery\\ for\\ drainage\\ of\\ the\\ abscess\\ as\\ well\\ as\\ submission\\ of\\ cultures\\ for\\ bacteria\\,\\ fungus\\,\\ and\\ mycobacteria\\,\\ which\\ were\\ all\\ negative\\.\\ \\ he\\ was\\ discharged\\ to\\ complete\\ a\\ four\\ week\\ total\\ course\\ of\\ antibiotic\\ therapy\\.\\ he\\ was\\ sent\\ home\\ on\\ oral\\ levofloxacin\\ \\(100\\ mg\\ twice\\ a\\ day\\)\\ as\\ well\\ as\\ doxycycline\\ \\(750\\ mg\\ once\\ daily\\)\\.\ \(0\)\
\-\ the\\ roof\\ of\\ the\\ left\\ orbit\\ is\\ depressed\\ and\\ there\\ is\\ soft\\ tissue\\ density\\ from\\ the\\ left\\ frontal\\ sinus\\ is\\ causing\\ proptosis\\ and\\ downward\\ displacement\\ of\\ the\\ left\\ globe\\.\\ there\\ is\\ mass\\ effect\\ on\\ the\\ left\\ superior\\ rectus\\ muscle\\.\\ this\\ suggests\\ at\\ least\\ some\\ component\\ of\\ orbital\\ involvement\\.\ \(0\)\
\-\ potts\\ puffy\\ tumor\ \(0\)\
\-\ cavernous\\ sinus\\ syndrome\ \(1\)\
\-\ epidural\\ hematoma\ \(39\)\
\-\ subarachnoid\\ hemorrhage\ \(52\)\
\-\ subdural\\ empyema\ \(8\)\
\-\ meningitis\ \(79\)\
\-\ brain\\ abscess\ \(13\)\
\-\ potts\\ puffy\\ tumor\ \(0\)\
\-\ this\\ is\\ an\\ 18\\ year\\-old\\ who\\ has\\ has\\ a\\ long\\ history\\ of\\ recurrent\\ sinus\\ infections\\ \\-\\ which\\ tend\\ to\ \(0\)\
\-\ worsen\\ in\\ the\\ winter\\.\\ approximately\\ one\\ month\\ ago\\,\\ he\\ was\\ started\\ on\\ a\\ course\\ of\\ antibiotics\\ for\\ increasing\\ sinus\\ pressure\\ and\\ drainage\\.\\ he\\ did\\ initially\\ have\\ some\\ improvement\\;\\ however\\,\\ once\\ he\\ completed\\ the\\ antibiotics\\ he\\ noted\\ worsening\\ again\\.\\ he\\ re\\-sought\\ care\\ in\\ the\\ ed\\ one\\ week\\ ago\\ after\\ he\\ was\\ noted\\ to\\ have\\ eyelid\\ edema\\.\\ at\\ that\\ time\\ he\\ was\\ started\\ on\\ bactrim\\ and\\ sent\\ home\\.\\ mom\\ felt\\ that\\ there\\ was\\ not\\ significant\\ improvement\\ over\\ the\\ course\\ of\\ the\\ week\\.\\ \\ they\\ noted\\ continued\\ worsening\\ of\\ his\\ eyelid\\ edema\\ and\\ some\\ proptosis\\.\\ they\\ re\\-sought\\ care\\ and\\ were\\ referred\\ to\\ an\\ ophthalmologist\\.\\ \\ \ \(0\)\
\-\ he\\ has\\ a\\ family\\ history\\ of\\ eczema\\ and\\ denies\\ any\\ allergies\\.\\ \\ he\\ denied\\ diplopia\\,\\ but\\ complained\\ of\\ vague\\ eye\\ pain\\ with\\ a\\ mild\\ frontal\\ headache\\.\ \(0\)\
\-\ this\\ was\\ a\\ case\\ of\\ potts\\ puffy\\ tumor\\ developing\\ after\\ sinusitis\\ with\\ a\\ previous\\ history\\ of\\ chronic\\ sinusitis\\.\\ \\ as\\ what\\ is\\ predominant\\ with\\ this\\ disease\\,\\ this\\ was\\ an\\ adolescent\\ male\\.\\ \\ on\\ presentation\\ this\\ patient\\ had\\ significant\\ proptosis\\,\\ eyelid\\ edema\\ with\\ a\\ mild\\ headache\\,\\ but\\ remained\\ afebrile\\.\\ \\ both\\ ct\\ and\\ mri\\ images\\ were\\ obtained\\ that\\ confirmed\\ the\\ presence\\ of\\ a\\ soft\\ tissue\\ density\\ from\\ the\\ left\\ frontal\\ sinus\\,\\ causing\\ proptosis\\ and\\ downward\\ displacement\\ of\\ the\\ left\\ globe\\.\\ \\ \\ the\\ proptosis\\ was\\,\\ however\\,\\ unlikely\\ related\\ to\\ direct\\ infection\\,\\ since\\ there\\ was\\ no\\ evidence\\ of\\ periosteal\\ abscess\\ in\\ the\\ roof\\ of\\ the\\ orbit\\ or\\ inflammatory\\ change\\ in\\ the\\ orbital\\ fat\\.\\ intravenous\\ vancomycin\\ and\\ meropenem\\ were\\ chosen\\ to\\ give\\ coverage\\ for\\ resistant\\ staphylococcus\\ aureus\\ as\\ well\\ as\\ gram\\-negative\\ and\\ aerobic\\ coverage\\ with\\ penetration\\ into\\ the\\ csf\\.\\ \\ surgical\\ drainage\\ was\\ also\\ completed\\.\\ \\ there\\ were\\ no\\ complications\\ in\\ this\\ cases\\ due\\ to\\ a\\ timely\\ diagnosis\\ and\\ treatment\\ and\\ appropriate\\ follow\\ up\\ with\\ the\\ specialists\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ he\\:\\ 0\\.05685661387996072\ \(0\)\
\-\ proptosis\\:\\ 0\\.045524328993309514\ \(0\)\
\-\ potts\\:\\ 0\\.04204539788855245\ \(0\)\
\-\ eyelid\\:\\ 0\\.038839225582602784\ \(0\)\
\-\ puffy\\:\\ 0\\.035433501094657906\ \(0\)\
\-\ re\\-sought\\:\\ 0\\.028030265259034973\ \(0\)\
\-\ vancomycin\\:\\ 0\\.02800196873513541\ \(0\)\
\-\ his\\:\\ 0\\.027408939894321974\ \(0\)\
\-\ downward\\:\\ 0\\.026505986737416606\ \(0\)\
\-\ sinus\\:\\ 0\\.024842281157730028\ \(0\)\
\-\ meropenem\\:\\ 0\\.023622334063105273\ \(0\)\
\-\ drainage\\:\\ 0\\.022726686225162836\ \(0\)\
\-\ orbit\\:\\ 0\\.02053096463012551\ \(0\)\
\-\ adolescent\\:\\ 0\\.020405796983046513\ \(0\)\
\-\ coverage\\:\\ 0\\.020129131237451504\ \(0\)\
\-\ edema\\:\\ 0\\.019212428373857636\ \(0\)\
\-\ was\\:\\ 0\\.01885426115511008\ \(0\)\
\-\ were\\:\\ 0\\.018508295739490505\ \(0\)\
\-\ as\\:\\ 0\\.018494749686879412\ \(0\)\
\-\ started\\:\\ 0\\.018179199291038343\ \(0\)\
\-\ has\\:\\ 0\\.017858346253513426\ \(0\)\
\-\ displacement\\:\\ 0\\.017466900617497862\ \(0\)\
\-\ left\\:\\ 0\\.01672044191097307\ \(0\)\
\-\ tongue\\:\\ 0\\.01654880925698656\ \(0\)\
\-\ some\\:\\ 0\\.01650192848245952\ \(0\)\
\-\ roof\\:\\ 0\\.016464013558792092\ \(0\)\
\-\ globe\\:\\ 0\\.01578814251909838\ \(0\)\
\-\ sinusitis\\:\\ 0\\.015721200041521805\ \(0\)\
\-\ completed\\:\\ 0\\.015655637920050466\ \(0\)\
\-\ course\\:\\ 0\\.01537932325972484\ \(0\)\
\-\ mg\\:\\ 0\\.014907421427413059\ \(0\)\
\-\ 13\\,700\\:\\ 0\\.014015132629517486\ \(0\)\
\-\ 132\\,000\\.\\:\\ 0\\.014015132629517486\ \(0\)\
\-\ once\\:\\ 0\\.013904188131879752\ \(0\)\
\-\ week\\:\\ 0\\.013841091025412852\ \(0\)\
\-\ sent\\:\\ 0\\.01383023944455299\ \(0\)\
\-\ least\\:\\ 0\\.01361818419972414\ \(0\)\
\-\ home\\:\\ 0\\.012915511074277056\ \(0\)\
\-\ naris\\:\\ 0\\.012913149830535061\ \(0\)\
\-\ mcg\\/ml\\:\\ 0\\.012913149830535061\ \(0\)\
\-\ levofloxacin\\:\\ 0\\.012913149830535061\ \(0\)\
\-\ 750\\:\\ 0\\.012913149830535061\ \(0\)\
\-\ orbital\\:\\ 0\\.012888217771601724\ \(0\)\
\-\ abscess\\:\\ 0\\.012886341386967887\ \(0\)\
\-\ frontal\\:\\ 0\\.012802664234419827\ \(0\)\
\-\ improvement\\:\\ 0\\.01267791633279554\ \(0\)\
\-\ afebrile\\:\\ 0\\.012553208182864598\ \(0\)\
\-\ is\\:\\ 0\\.012515216053078154\ \(0\)\
\-\ well\\:\\ 0\\.01229304262619174\ \(0\)\
\-\ timely\\:\\ 0\\.012268531216690602\ \(0\)\
\-\ count\\:\\ 0\\.011814473755619396\ \(0\)\
\-\ trough\\:\\ 0\\.011811167031552636\ \(0\)\
\-\ bactrim\\:\\ 0\\.011811167031552636\ \(0\)\
\-\ causing\\:\\ 0\\.011737851969994401\ \(0\)\
\-\ 13\\.7\\:\\ 0\\.01145640780847758\ \(0\)\
\-\ gm\\/dl\\:\\ 0\\.01145640780847758\ \(0\)\
\-\ doxycycline\\:\\ 0\\.01145640780847758\ \(0\)\
\-\ specialists\\:\\ 0\\.01145640780847758\ \(0\)\
\-\ eye\\:\\ 0\\.011397169497971102\ \(0\)\
\-\ bluish\\:\\ 0\\.011166548417708177\ \(0\)\
\-\ maximize\\:\\ 0\\.011166548417708177\ \(0\)\
\-\ mycobacteria\\:\\ 0\\.011166548417708177\ \(0\)\
\-\ eczema\\:\\ 0\\.011166548417708177\ \(0\)\
\-\ gram\\-negative\\:\\ 0\\.011166548417708177\ \(0\)\
\-\ significant\\:\\ 0\\.010959525362738743\ \(0\)\
\-\ winter\\:\\ 0\\.01092147579477136\ \(0\)\
\-\ aerobic\\:\\ 0\\.01092147579477136\ \(0\)\
\-\ interactive\\:\\ 0\\.010709184232570211\ \(0\)\
\-\ worsening\\:\\ 0\\.010697869540225113\ \(0\)\
\-\ this\\:\\ 0\\.010696280593321035\ \(0\)\
\-\ id\\:\\ 0\\.010521929803863718\ \(0\)\
\-\ 15\\-20\\:\\ 0\\.010354425009495155\ \(0\)\
\-\ antibiotics\\:\\ 0\\.010205775382100163\ \(0\)\
\-\ discoloration\\:\\ 0\\.010202898491523256\ \(0\)\
\-\ ago\\:\\ 0\\.010113605153568359\ \(0\)\
\-\ there\\:\\ 0\\.010109026680961754\ \(0\)\
\-\ ophthalmologist\\:\\ 0\\.010064565618725752\ \(0\)\
\-\ worsen\\:\\ 0\\.009937311711454629\ \(0\)\
\-\ chosen\\:\\ 0\\.009937311711454629\ \(0\)\
\-\ soft\\:\\ 0\\.009924928922067805\ \(0\)\
\-\ care\\:\\ 0\\.009800245300695556\ \(0\)\
\-\ they\\:\\ 0\\.009789971785333248\ \(0\)\
\-\ platelet\\:\\ 0\\.009709806395650696\ \(0\)\
\-\ tissue\\:\\ 0\\.009660196447309668\ \(0\)\
\-\ noted\\:\\ 0\\.009660196447309668\ \(0\)\
\-\ submission\\:\\ 0\\.009607201433587785\ \(0\)\
\-\ fungus\\:\\ 0\\.009607201433587785\ \(0\)\
\-\ tumor\\:\\ 0\\.009501902869367938\ \(0\)\
\-\ 18\\.\\:\\ 0\\.009419947004881295\ \(0\)\
\-\ staphylococcus\\:\\ 0\\.009419947004881295\ \(0\)\
\-\ headache\\:\\ 0\\.009332227146473126\ \(0\)\
\-\ give\\:\\ 0\\.00925244221051273\ \(0\)\
\-\ mom\\:\\ 0\\.009174874381944476\ \(0\)\
\-\ resistant\\:\\ 0\\.009174874381944476\ \(0\)\
\-\ edges\\:\\ 0\\.008962582819743327\ \(0\)\
\-\ aureus\\:\\ 0\\.008962582819743327\ \(0\)\
\-\ penetration\\:\\ 0\\.008962582819743327\ \(0\)\
\-\ density\\:\\ 0\\.008940004314340094\ \(0\)\
\-\ 88\\:\\ 0\\.008897682987437676\ \(0\)\
\-\ forehead\\:\\ 0\\.008835328912472204\ \(0\)\
\-\ warmth\\:\\ 0\\.008775328391036835\ \(0\)\
\-\ predominant\\:\\ 0\\.008775328391036835\ \(0\)\
\-\ but\\:\\ 0\\.008692384583625775\ \(0\)\
\-\ twice\\:\\ 0\\.008661721135103377\ \(0\)\
\-\ moist\\:\\ 0\\.008607823596668271\ \(0\)\
\-\ bacteria\\:\\ 0\\.008607823596668271\ \(0\)\
\-\ depressed\\:\\ 0\\.008555693512688955\ \(0\)\
\-\ after\\:\\ 0\\.008432438168247389\ \(0\)\
\-\ normocephalic\\:\\ 0\\.00831796420589887\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.00827440462849328\ \(0\)\
\-\ consulted\\:\\ 0\\.00827440462849328\ \(0\)\
\-\ empyema\\:\\ 0\\.00827440462849328\ \(0\)\
\-\ ent\\:\\ 0\\.008150459411530305\ \(0\)\
\-\ onto\\:\\ 0\\.008111202475774548\ \(0\)\
\-\ on\\:\\ 0\\.008056020805338626\ \(0\)\
\-\ continuous\\:\\ 0\\.007963204982823813\ \(0\)\
\-\ membranes\\:\\ 0\\.007963204982823813\ \(0\)\
\-\ allergies\\:\\ 0\\.007963204982823813\ \(0\)\
\-\ diplopia\\:\\ 0\\.00792826236482894\ \(0\)\
\-\ erythematous\\:\\ 0\\.00789407125954919\ \(0\)\
\-\ rectus\\:\\ 0\\.007860600020760902\ \(0\)\
\-\ mucous\\:\\ 0\\.007827818960025233\ \(0\)\
\-\ tend\\:\\ 0\\.007703062814649248\ \(0\)\
\-\ which\\:\\ 0\\.007608002800838865\ \(0\)\
\-\ a\\:\\ 0\\.007566291926586987\ \(0\)\
\-\ however\\:\\ 0\\.007565558205396091\ \(0\)\
\-\ an\\:\\ 0\\.007514561935038028\ \(0\)\
\-\ blood\\:\\ 0\\.007416251422923051\ \(0\)\
\-\ remained\\:\\ 0\\.007403235835622935\ \(0\)\
\-\ one\\:\\ 0\\.007363215845184878\ \(0\)\
\-\ subdural\\:\\ 0\\.007354314279713947\ \(0\)\
\-\ \\,\\:\\ 0\\.007316488257223984\ \(0\)\
\-\ vague\\:\\ 0\\.007306853289014931\ \(0\)\
\-\ patchy\\:\\ 0\\.0072836437509844814\ \(0\)\
\-\ culture\\:\\ 0\\.007238217085731611\ \(0\)\
\-\ complained\\:\\ 0\\.007172421829510856\ \(0\)\
\-\ what\\:\\ 0\\.007172421829510856\ \(0\)\
\-\ mild\\:\\ 0\\.00715501893141856\ \(0\)\
\-\ developing\\:\\ 0\\.00710924165677713\ \(0\)\
\-\ meningitis\\:\\ 0\\.00704847661254788\ \(0\)\
\-\ that\\:\\ 0\\.007039653713317122\ \(0\)\
\-\ daily\\:\\ 0\\.007028726978209951\ \(0\)\
\-\ pulse\\:\\ 0\\.007009219676792123\ \(0\)\
\-\ cultures\\:\\ 0\\.006989948833338474\ \(0\)\
\-\ septum\\:\\ 0\\.006952094065939876\ \(0\)\
\-\ antibiotic\\:\\ 0\\.006952094065939876\ \(0\)\
\-\ 100\\:\\ 0\\.0068612221838413884\ \(0\)\
\-\ suggests\\:\\ 0\\.006792088460566764\ \(0\)\
\-\ alert\\:\\ 0\\.006775264757338566\ \(0\)\
\-\ intravenous\\:\\ 0\\.0067421422026440634\ \(0\)\
\-\ epidural\\:\\ 0\\.006693717389472825\ \(0\)\
\-\ erythema\\:\\ 0\\.006677898103537741\ \(0\)\
\-\ localized\\:\\ 0\\.006616149560904572\ \(0\)\
\-\ denied\\:\\ 0\\.006616149560904572\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.006601080015666823\ \(0\)\
\-\ again\\:\\ 0\\.006527803215666398\ \(0\)\
\-\ unlikely\\:\\ 0\\.00647152034277146\ \(0\)\
\-\ infections\\:\\ 0\\.006457755537138528\ \(0\)\
\-\ shift\\:\\ 0\\.006444108885800862\ \(0\)\
\-\ periosteal\\:\\ 0\\.006444108885800862\ \(0\)\
\-\ direct\\:\\ 0\\.006417162052233655\ \(0\)\
\-\ appropriate\\:\\ 0\\.006403857998703423\ \(0\)\
\-\ without\\:\\ 0\\.0063974981442230855\ \(0\)\
\-\ felt\\:\\ 0\\.006390664353529025\ \(0\)\
\-\ cavernous\\:\\ 0\\.006301253036640511\ \(0\)\
\-\ discharged\\:\\ 0\\.006228423885557372\ \(0\)\
\-\ component\\:\\ 0\\.006204870490032506\ \(0\)\
\-\ to\\:\\ 0\\.00611067245784877\ \(0\)\
\-\ from\\:\\ 0\\.006040233926013731\ \(0\)\
\-\ the\\:\\ 0\\.005934389009535607\ \(0\)\
\-\ growth\\:\\ 0\\.005907236877809698\ \(0\)\
\-\ four\\:\\ 0\\.005897572257656467\ \(0\)\
\-\ 18\\:\\ 0\\.005897572257656467\ \(0\)\
\-\ have\\:\\ 0\\.005883745877154505\ \(0\)\
\-\ had\\:\\ 0\\.005862797517458532\ \(0\)\
\-\ total\\:\\ 0\\.005850111266957451\ \(0\)\
\-\ continued\\:\\ 0\\.005850111266957451\ \(0\)\
\-\ ed\\:\\ 0\\.005741672077726078\ \(0\)\
\-\ recurrent\\:\\ 0\\.005732960685413478\ \(0\)\
\-\ denies\\:\\ 0\\.005732960685413478\ \(0\)\
\-\ oral\\:\\ 0\\.00572429676686409\ \(0\)\
\-\ csf\\:\\ 0\\.005673281958356141\ \(0\)\
\-\ respiratory\\:\\ 0\\.0056401594036616385\ \(0\)\
\-\ history\\:\\ 0\\.005629004154405803\ \(0\)\
\-\ related\\:\\ 0\\.005607712866887064\ \(0\)\
\-\ prominent\\:\\ 0\\.005575915304555316\ \(0\)\
\-\ increasing\\:\\ 0\\.005568064300357251\ \(0\)\
\-\ family\\:\\ 0\\.005568064300357251\ \(0\)\
\-\ initially\\:\\ 0\\.005529380515524929\ \(0\)\
\-\ at\\:\\ 0\\.005521922827495865\ \(0\)\
\-\ complications\\:\\ 0\\.005383422567586737\ \(0\)\
\-\ pressure\\:\\ 0\\.005335346438509284\ \(0\)\
\-\ marked\\:\\ 0\\.005301875199720997\ \(0\)\
\-\ rate\\:\\ 0\\.00529526469074061\ \(0\)\
\-\ change\\:\\ 0\\.00529526469074061\ \(0\)\
\-\ previous\\:\\ 0\\.005275596500275511\ \(0\)\
\-\ active\\:\\ 0\\.005186897995301878\ \(0\)\
\-\ referred\\:\\ 0\\.005126441086574947\ \(0\)\
\-\ confirmed\\:\\ 0\\.005108743407133224\ \(0\)\
\-\ year\\-old\\:\\ 0\\.00499008683894788\ \(0\)\
\-\ since\\:\\ 0\\.00499008683894788\ \(0\)\
\-\ involvement\\:\\ 0\\.004979234748215925\ \(0\)\
\-\ presence\\:\\ 0\\.004931296690710857\ \(0\)\
\-\ did\\:\\ 0\\.00490527605881228\ \(0\)\
\-\ otherwise\\:\\ 0\\.004879674456957623\ \(0\)\
\-\ muscle\\:\\ 0\\.004879674456957623\ \(0\)\
\-\ hematoma\\:\\ 0\\.004834605530082814\ \(0\)\
\-\ obtained\\:\\ 0\\.004829675835840767\ \(0\)\
\-\ effect\\:\\ 0\\.004810108510443951\ \(0\)\
\-\ complete\\:\\ 0\\.004781201802839514\ \(0\)\
\-\ inflammatory\\:\\ 0\\.004711154124311644\ \(0\)\
\-\ long\\:\\ 0\\.0046839769647579075\ \(0\)\
\-\ presentation\\:\\ 0\\.0046794922646917056\ \(0\)\
\-\ for\\:\\ 0\\.004636617797409953\ \(0\)\
\-\ and\\:\\ 0\\.0045789254240309945\ \(0\)\
\-\ extending\\:\\ 0\\.004567120904355799\ \(0\)\
\-\ cases\\:\\ 0\\.0045259314212736605\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.004521870563077958\ \(0\)\
\-\ white\\:\\ 0\\.004505730067904639\ \(0\)\
\-\ along\\:\\ 0\\.004489751791507975\ \(0\)\
\-\ bilaterally\\:\\ 0\\.004462170490499052\ \(0\)\
\-\ superior\\:\\ 0\\.004338225273536076\ \(0\)\
\-\ follow\\:\\ 0\\.004316692324239164\ \(0\)\
\-\ day\\:\\ 0\\.004313131684185898\ \(0\)\
\-\ any\\:\\ 0\\.004277957127300944\ \(0\)\
\-\ approximately\\:\\ 0\\.004203207991344329\ \(0\)\
\-\ days\\:\\ 0\\.0041638701052018725\ \(0\)\
\-\ fat\\:\\ 0\\.0041318160936115\ \(0\)\
\-\ no\\:\\ 0\\.004103867173468054\ \(0\)\
\-\ brain\\:\\ 0\\.004087999242134757\ \(0\)\
\-\ patient\\:\\ 0\\.004085494106119497\ \(0\)\
\-\ month\\:\\ 0\\.004075698793005738\ \(0\)\
\-\ of\\:\\ 0\\.004074854717894667\ \(0\)\
\-\ negative\\:\\ 0\\.004057424739864666\ \(0\)\
\-\ 5\\:\\ 0\\.00397481784172363\ \(0\)\
\-\ infection\\:\\ 0\\.003949151946061697\ \(0\)\
\-\ level\\:\\ 0\\.003915562842045997\ \(0\)\
\-\ syndrome\\:\\ 0\\.0038853840647609566\ \(0\)\
\-\ head\\:\\ 0\\.0038531022425658127\ \(0\)\
\-\ all\\:\\ 0\\.003842485674771528\ \(0\)\
\-\ time\\:\\ 0\\.00383720385888603\ \(0\)\
\-\ chronic\\:\\ 0\\.003826692580138315\ \(0\)\
\-\ cell\\:\\ 0\\.0036696990645174662\ \(0\)\
\-\ up\\:\\ 0\\.003653175120912915\ \(0\)\
\-\ therapy\\:\\ 0\\.003632179326296682\ \(0\)\
\-\ due\\:\\ 0\\.0036252418965863906\ \(0\)\
\-\ evidence\\:\\ 0\\.003561911897244639\ \(0\)\
\-\ who\\:\\ 0\\.003542080141719717\ \(0\)\
\-\ both\\:\\ 0\\.0034693163603912902\ \(0\)\
\-\ over\\:\\ 0\\.003458891240286109\ \(0\)\
\-\ more\\:\\ 0\\.0033977365807824587\ \(0\)\
\-\ in\\:\\ 0\\.003349739508269117\ \(0\)\
\-\ surgery\\:\\ 0\\.003298885634912997\ \(0\)\
\-\ into\\:\\ 0\\.0032326333353890416\ \(0\)\
\-\ \\;\\:\\ 0\\.0032200654824365562\ \(0\)\
\-\ or\\:\\ 0\\.0031844920475793564\ \(0\)\
\-\ mri\\:\\ 0\\.003121265270134531\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0031195855815269\ \(0\)\
\-\ case\\:\\ 0\\.002972185107897092\ \(0\)\
\-\ lateral\\:\\ 0\\.0029358792458259943\ \(0\)\
\-\ \\-\\:\\ 0\\.002912127915275618\ \(0\)\
\-\ surgical\\:\\ 0\\.002855678490065904\ \(0\)\
\-\ treatment\\:\\ 0\\.0027497884890316173\ \(0\)\
\-\ also\\:\\ 0\\.0026782505463754393\ \(0\)\
\-\ images\\:\\ 0\\.0026061429124791006\ \(0\)\
\-\ male\\:\\ 0\\.0024566065785174454\ \(0\)\
\-\ \\(\\:\\ 0\\.002296857635115614\ \(0\)\
\-\ \\)\\:\\ 0\\.0022688002928880928\ \(0\)\
\-\ disease\\:\\ 0\\.002220568428005889\ \(0\)\
\-\ \\.\\:\\ 0\\.002144646059935069\ \(0\)\
\-\ normal\\:\\ 0\\.0021297495303642306\ \(0\)\
\-\ not\\:\\ 0\\.0019631457420380533\ \(0\)\
\-\ ct\\:\\ 0\\.0019003237732782877\ \(0\)\
\-\ mass\\:\\ 0\\.001889445162078799\ \(0\)\
\-\ are\\:\\ 0\\.001851945743290305\ \(0\)\
\-\ pain\\:\\ 0\\.0016591544793811363\ \(0\)\
\-\ right\\:\\ 0\\.0014334367394442237\ \(0\)\
\-\ with\\:\\ 0\\.001302113247423256\ \(0\)\
